Finally, non-Hodgkin lymphoma cells showed greater mRNA expression of CB1 and/or CB2 receptors compared to that observed in reactive lymphoid tissue [170], and an increased expression of CB1 and CB2 receptors was observed in mantle cell lymphoma cells with respect to normal B lymphocytes and reactive lymphoid cells [171]. The gene discussed is CNR1; the disease is mantle cell lymphoma.